# Commission Implementing Regulation (EU) No 103/2013 of 4 February 2013 amending Regulation (EC) No 786/2007 as regards the name of the holder of the authorisation of a preparation of endo-1,4-beta-mannanase EC 3.2.1.78 (Hemicell) (Text with EEA relevance), Article 2

Extent: E+W+S+N.I.

Existing stocks of the additive which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until they are exhausted.

---
Source: https://www.legislation.gov.uk/eur/2013/103/article/2 (the official version)
Page: https://openlegislation.uk/eu-regulation-2013-103/article-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.